08048036315
Ramiven 150 mg Tablet UK Wholesale – Glasgow | Competitive Prices | Phoenix Exim | Trusted Exporter

1. General Information

Ramiven 150 mg Tablet is an oral anticancer medicine containing Abemaciclib 150 mg. It is a targeted therapy that works differently from traditional chemotherapy by selectively inhibiting proteins involved in cancer-cell division.

It is a prescription-only medicine and should be used under the supervision of an oncologist. Regular medical monitoring, including blood tests, may be required during treatment.

Key information:

  • Brand: Ramiven 150 mg Tablet
  • Active ingredient: Abemaciclib 150 mg
  • Drug class: CDK4/6 inhibitor
  • Therapeutic class: Anticancer/antineoplastic
  • Dosage form: Oral tablet
  • Prescription: Required
  • Common pack information: 14 tablets, depending on market/packaging
  • Manufacturer/marketer: Eli Lilly and Company India Pvt Ltd is listed for the Indian product.

2. Product Information

Abemaciclib is a targeted cancer therapy that inhibits cyclin-dependent kinases 4 and 6 (CDK4/6). Ramiven 150 mg is available as an oral tablet and may be prescribed alone in selected advanced disease or alongside endocrine therapy, depending on the patient's clinical situation.

The exact treatment schedule is determined by the oncologist according to the indication, accompanying medicines, response to treatment and tolerability.

3. Uses of Ramiven 150 mg

Ramiven 150 mg is used in the treatment of certain forms of HR-positive, HER2-negative breast cancer. Its uses can include:

  • Advanced or metastatic HR-positive, HER2-negative breast cancer
  • Certain early-stage HR-positive, HER2-negative breast cancers with a high risk of recurrence
  • Treatment in combination with endocrine therapies such as an aromatase inhibitor or fulvestrant in appropriate patients
  • In selected advanced/metastatic patients, abemaciclib may also be used as monotherapy after previous treatments.

The exact indication and combination should always be determined by a qualified oncologist.

4. Benefits of Ramiven 150 mg

The principal benefit of Ramiven is its targeted inhibition of CDK4 and CDK6, proteins that help cancer cells progress through the cell cycle.

Potential therapeutic benefits include:

  • Helps slow the multiplication of cancer cells
  • Helps delay progression of certain HR-positive, HER2-negative breast cancers
  • Can be combined with hormone/endocrine therapy when clinically appropriate
  • Provides an oral targeted-treatment option
  • Can help control advanced or metastatic disease in appropriate patients.

Treatment benefits vary between patients and should be assessed through medical examinations and appropriate imaging/laboratory tests.

5. Side Effects of Ramiven 150 mg

Ramiven can cause side effects, and some can require medical attention. Reported adverse effects include:

  • Diarrhea
  • Fatigue
  • Nausea
  • Abdominal discomfort
  • Infection
  • Reduced white blood cell counts/neutropenia
  • Anemia or other blood-count abnormalities
  • Increased liver enzymes
  • Headache
  • Hair loss
  • Decreased appetite or weight loss
  • Stomatitis/mouth inflammation
  • Dizziness
  • Joint pain
  • Increased creatinine levels.

Serious reactions can include severe neutropenia, liver toxicity, interstitial lung disease/pneumonitis and venous thromboembolic events. Symptoms such as breathing difficulty, chest pain, severe fever or yellowing of the skin/eyes require prompt medical evaluation.

6. Common Side Effects

Some of the more frequently reported side effects include:

  1. Diarrhea
  2. Fatigue
  3. Nausea
  4. Abdominal pain/discomfort
  5. Headache
  6. Infection
  7. Decreased white blood cell count
  8. Anemia
  9. Hair loss
  10. Reduced appetite
  11. Increased liver enzymes
  12. Joint pain

Diarrhea is particularly important because it can occur early during treatment and may become serious if persistent or severe. Adequate hydration and prompt communication with the treating doctor are important.

7. How to Use Ramiven 150 mg

  • Take Ramiven exactly as prescribed by your oncologist.
  • It may generally be taken with or without food.
  • Swallow the tablet whole with water.
  • Do not crush, chew or break the tablet unless specifically instructed by your healthcare professional.
  • Take it consistently at approximately the same time each day.
  • If you vomit after taking a dose, do not automatically take another dose; follow your doctor's instructions.
  • Do not discontinue treatment without consulting your oncologist.

The appropriate dose and treatment duration depend on the cancer type, treatment regimen, other medicines and individual tolerance.

8. How Ramiven 150 mg Works

Ramiven contains Abemaciclib, which blocks the activity of CDK4 and CDK6.

These proteins help regulate progression of cells through the cell cycle. By inhibiting CDK4/6, abemaciclib interferes with cancer-cell proliferation and helps slow the growth and progression of susceptible breast cancer cells.

Unlike conventional chemotherapy, abemaciclib is a targeted therapy designed to act on specific molecular pathways involved in cancer-cell growth.

9. Safety Advice for Ramiven 150 mg

Pregnancy: Abemaciclib can potentially harm an unborn baby. Patients who can become pregnant should discuss effective contraception with their healthcare provider.

Breastfeeding: Breastfeeding is generally not recommended during treatment because of potential risk to the infant.

Liver problems: Patients with significant liver impairment may require additional monitoring or dose adjustment.

Kidney problems: Tell your doctor about kidney disease before treatment; dose adjustments may be necessary in certain circumstances.

Blood counts: Regular blood tests may be required because Ramiven can reduce blood-cell counts and increase infection risk.

Diarrhea: Contact your doctor if diarrhea is severe or persistent and maintain adequate fluid intake.

Drug interactions: Certain medicines can substantially change abemaciclib levels. Examples include some strong CYP3A inhibitors and inducers, so provide your doctor with a complete list of prescription medicines, OTC products and supplements.

Grapefruit: Grapefruit and grapefruit juice may increase abemaciclib exposure and are generally advised to be avoided during treatment.

10. Frequently Asked Questions

Q1. What is Ramiven 150 mg Tablet?
Ramiven 150 mg is an oral anticancer medicine containing Abemaciclib 150 mg, a CDK4/6 inhibitor used for certain HR-positive, HER2-negative breast cancers.

Q2. Is Ramiven a chemotherapy medicine?
No. Abemaciclib is considered a targeted CDK4/6 inhibitor rather than conventional cytotoxic chemotherapy.

Q3. What is Ramiven 150 mg used for?
It is used for certain HR-positive, HER2-negative breast cancers, including selected advanced/metastatic and high-risk early-stage disease.

Q4. Can Ramiven be taken with food?
Yes, it may generally be taken with or without food.

Q5. What is the most important common side effect?
Diarrhea is one of the most common adverse effects and should be managed promptly if persistent or severe.

Q6. Does Ramiven require a prescription?
Yes. It is a prescription anticancer medicine and should be used under specialist medical supervision.

Q7. Can I stop Ramiven when I feel better?
No. Treatment should not be stopped or changed without consulting the treating oncologist.

Q8. Does Ramiven require blood tests?
Yes. Doctors commonly monitor blood counts and liver function during treatment.

11. Substitutes for Ramiven 150 mg

Because Ramiven contains Abemaciclib 150 mg, an appropriate substitute should generally be considered based on the same active ingredient and strength, rather than simply selecting another breast-cancer medicine.

The original branded abemaciclib product is Verzenio in the United States and some other markets. Other abemaciclib brands/generics may exist depending on the country. A substitute should only be selected by a physician or pharmacist because oncology medicines are not automatically interchangeable.

Important: Do not replace Ramiven with another CDK4/6 inhibitor such as palbociclib or ribociclib without medical advice; they have different dosing, interactions and clinical indications.

12. SEO & B2B Keywords for Phoenix Exim

For pharmaceutical B2B catalog/SEO purposes, you can use keywords such as:

  • Ramiven 150 mg Tablet exporter from India
  • Ramiven 150 mg Tablet supplier India
  • Ramiven 150 mg Abemaciclib exporter
  • Abemaciclib 150 mg Tablet supplier
  • Abemaciclib 150 mg pharmaceutical exporter
  • Ramiven 150 mg wholesale supplier
  • Ramiven 150 mg international supplier
  • Ramiven 150 mg Tablet export from Nagpur
  • Ramiven 150 mg medicine exporter Nagpur India
  • Abemaciclib oncology medicine exporter India
  • Ramiven 150 mg breast cancer medicine
  • HR positive HER2 negative breast cancer medicine supplier
  • Abemaciclib 150 mg oncology supplier
  • Ramiven 150 mg supplier USA
  • Ramiven 150 mg supplier UK
  • Ramiven 150 mg supplier Australia
  • Ramiven 150 mg supplier Singapore
  • Ramiven 150 mg supplier Canada
  • Ramiven 150 mg supplier South Korea
  • Ramiven 150 mg supplier UAE
  • Abemaciclib 150 mg exporter to USA
  • Abemaciclib 150 mg exporter to UK
  • Abemaciclib 150 mg exporter to Australia
  • Abemaciclib 150 mg exporter to Canada
  • Abemaciclib 150 mg exporter to UAE
  • oncology pharmaceutical exporter from India
  • breast cancer medicine exporter India
  • prescription oncology medicines supplier
  • pharmaceutical export company Nagpur India
  • Phoenix Exim Ramiven 150 mg supplier
Aug 12th, 2026 3:00 PM

Keywords